Despite the tumor-promoting effects of estrogen in ER+ breast cancer, studies have demonstrated that long-term estrogen deprivation or anti-estrogen treatment can resensitize cells to cell death-inducing effects of estrogen. This evidence concerns the gene ESR1 and breast cancer.